| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1189b3e264e46cc61ed41e07108fac59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9fcb27564ee6aa5714a90f5e8ad7852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83e7381962e3fd0b25c26d90014c1301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3fe3a235814fa04e6c5f4c832d32fe2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2004-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fff80deb3eb9483b0a72e45766c32e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c4f113c3ff586a2329adc499e37d129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d505a27348b84ddd0505ba4c1942ce |
| publicationDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004083449-A2 |
| titleOfInvention |
Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| abstract |
The invention relates to methods and kits for assessing occurrence in woman urine of peptides having amino acid sequences related to those of mesothelin, megakaryocyte potentiating factor, and other peptides that have been associated with occurrence in the serum of ovarian cancer patients. The methods and kits can be used to diagnose ovarian cancer in a woman, to predict development of ovarian cancer in an otherwise asymptomatic woman, or to assess the efficacy of an ovarian cancer therapeutic method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106841190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2444805-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1714151-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1714151-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1716168-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1716168-A2 |
| priorityDate |
2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |